Ved­aBio launch­es with $40M+ in ini­tial fund­ing for CRISPR-based mol­e­c­u­lar de­tec­tion tech­nol­o­gy

Cal­i­for­nia biotech Ved­aBio de­buted on Tues­day with more than $40 mil­lion in ear­ly fund­ing to sup­port its CRISPR-dri­ven mol­e­c­u­lar de­tec­tion plat­form, which it claims could …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER